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Abstract Horn cancer (HC) is a squamous cell carcinoma
of horn, commonly observed in Bos indicus of the Asian
countries. To elucidate the complexity of alternative
splicing present in the HC, high-throughput sequencing and
analysis of HC and matching horn normal (HN) tissue were
carried out. A total of 535,067 and 849,077 reads were
analysed after stringent quality filtering for HN and HC,
respectively. Cufflinks pipeline for transcriptome analysis
revealed 4786 novel splice isoforms comprising 2432
exclusively in HC, 2055 exclusively in HN and 298 in both
the conditions. Based on pathway clustering and in silico
verification, 102 novel splice isoforms were selected and
further analysed with respect to change in protein sequence
using Blastp. Finally, fourteen novel splicing events sup-
ported both by Cufflinks and UCSC genome browser were
selected and confirmed expression by RT-qPCR. Future
studies targeted at in-depth characterization of these
potential candidate splice isoforms might be helpful in the
development of relevant biomarkers for early diagnosis of
HC. The results reported in this study refine the available
information on transcriptome repertoire of bovine species
and boost the research in the line of development of rele-
vant biomarkers for early diagnosis of HC.
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Cancer is a multifactorial disease affecting almost every
species of animals and human. Various types of cancers are
prevalent in farm animals causing moderate to severe
economic losses. Horn cancer (HC, cancerous tissue from
affected horn) is amongst widely prevalent cancer reported
in Indian zebu cattle (Bos indicus), drawing recent atten-
tion towards the necessity of in-depth studies for better
understanding. HC is a progressive cancer which is clas-
sified into three different stages based on the growth of
tumour tissue in the affected horn. The incidence of HC in
India is more commonly seen in Kankrej breed than other
zebu and crossbred cattle (Joshi et al. 2009; Udharwar et al.
2008). Exceptional few cases of HC have been reported
from other countries like Sumatra (Burggraaf 1935), Brazil
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(Rezende and Naves 1975) and Iraq (Zubaidy 1976). The
mainly affected animals are Bullocks (95%) in comparison
to cows (5%), whereas it is rarely reported in bulls, buf-
faloes, sheep and goats (Chattopadhyay et al. 1982;
Damodaran et al. 1979; Gupta et al. 1980; Kulkarni 1953).
HC is a squamous cell carcinoma of horn arising from
pseudo-stratified columnar epithelium of the horn core
mucosa. The main difficulties in early diagnosis include the
absence of specific markers and the lack of a complete
understanding of the cellular hierarchy of morphogenesis
of the horn core epithelium. At molecular level, HC has
been studied previously for novel gene content (Jakhesara
et al. 2013b) and global gene expression (Tripathi et al.
2012).
Horn cancer involves complex interplay of several genes
which are up-regulated or down-regulated and results in the
transformation of normal horn tissue to malignant one. In
horn cancer, the interplay of three genes KRT6A, KRT6B,
and KRT6C has been observed in cancer. Over and above
these keratin protein family members, there is also up-
regulation of a novel candidate KRT84. Other genes of
keratin family, KRT14 and KRT5, are specifically expres-
sed in the basal layer of the epidermis and found to be up-
regulated in HC. Gene KRT14 expression can be consid-
ered as a candidate of proliferative activity and metastatic
potential of SCC in horn. Besides keratin family genes,
Stratifin (SFN), Anilin (ANLN), NR4A1 and SCGB1A1
(Uteroglobin) were also significantly up-regulated in HC
tissue. While, a number of genes were observed to be
down-regulated in HC including CXCL17, KRT19 and
BPIFB1 which are known to be involved in anti-tumour
immune reactions. CXCL17 has also been reported to have
potential tumour suppressor activity (Hiraoka et al. 2011).
BPIFB1 is commonly known as long palate, lung and nasal
epithelium carcinoma-associated protein 1 (LPLUNC1)
expressed in the epithelium of upper respiratory tract
(Bingle et al. 2010). Additional details about commonly
expressed genes in HC are described elsewhere (Koringa
et al. 2013).
Amongst diverse type of changes present in the cancer,
overrepresentation of aberrant mRNA transcripts is the
most common and widely reported observation (Jakhesara
et al. 2013a; Li et al. 2013; Erho et al. 2012). Alternative
splicing (AS) is the phenomenon by which the exons of
primary transcripts are used alternatively to produce
structurally and functionally distinct mRNA (splice iso-
forms) and protein variants, which might be one of the
most extensively used mechanisms that accounts for the
greater cellular complexity of higher eukaryotic organ-
isms (Irimia and Blencowe 2012). Cancer cells may
exhibit defective regulation of this alternative exon usage
that can result in changes with potential transcriptome-
wide consequences to gene function. It is imperative that
AS can result in increased protein repertoire of the cell
encoding alternative protein forms with biological func-
tions that differ from the canonical product of the locus.
AS transcripts exhibit changes to the primary transcript
and might result in transcripts and/or protein isoforms
with loss or disruption of domains responsible for original
function.
Detailed investigation and understanding of complexity
of AS events exhibited by cancer cells are very important
as it provides important clues about structural and func-
tional consequences of deregulated genes. Until recently,
profound cost, limited coverage and sensitivity of the
sequencing and microarray studies were hindering the
global study of AS events in the cell; however, with
advancement in the next-generation sequencing technolo-
gies now it is possible to do the same. Although, HC has
been studied recently for detection of AS events, the
information generated was on limited scale, with small size
of dataset and analysis lacking RNA-Seq-specific pipeline
(Patel et al. 2013). In the present study, we employed high-
throughput pyro sequencing combined with Cufflinks
workflow optimized for RNA-Seq to elucidate complexity
of the AS in HC transcriptome. Here, we report AS events
exhibited in HC and HN tissue and confirmed their sig-
nificant association with HC by RT-qPCR.
Materials and methods
Tissue collection and RNA sequencing
All experimental protocols were performed as per
guidelines and approval of Institutional Animal Ethics
Committee of the Anand Agricultural University (Permit
Number 486). Detailed summary of methods employed
for tissue collection and sequencing is described else-
where (Jakhesara et al. 2013b). Briefly, after mRNA
isolation from collected tissues of HC and HN, cDNA
libraries were prepared and sequenced on GS FLX Tita-
nium following manufacturer protocol (Roche Diagnos-
tics, Switzerland).
Mapping of RNA-Seq reads using GMAP
After signal processing and trimming, available reads were
aligned to the UCSC Bos taurus reference genome (build
bosTau7) using GMAP v2012-06-06 (Wu and Watanabe
2005). Whenever required, we used SAM Tools v0.1.18 (Li
et al. 2009) to convert SAM files to BAM file and vice
versa. Mapping results were visualized using a local copy
of the Integrative Genomics Viewer v 2.1.17 (Thorvalds-
dottir et al. 2012) software available at http://www.
broadinstitute.org/igv/.
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Transcript assembly using Cufflinks
The read alignments from GMAP were processed by
Cufflinks v2.0.0 (Trapnell et al. 2010) for assembly of the
reads into transcripts; their abundance estimation and tests
for differential expression between the cancer and normal
tissue samples were performed using Cufflinks. Cufflinks
also uses reference annotation-based transcript (RABT)
assembly method (Roberts et al. 2011), to assemble against
a known reference annotation to better identify novel
transcripts. Cufflinks measures transcript abundances in
Fragments Per Kilobase of exon per Million fragments
mapped (FPKM), which is analogous to single-read
‘‘RPKM’’. Cufflinks was run with default parameters for
RABT assembly method.
Comparison to reference annotation and differential
analysis
Once assembly of alignments of reads to transcripts is
completed; the transcripts.gtf files from Cufflinks were
used as input to Cuffcompare along with reference anno-
tation file refFlat.gtf file downloaded from UCSC Genome
Browser Database (build Btau7) (Dreszer et al. 2012).
Combined.gtf file produced by Cuffcompare was provided
as input to Cuffdiff along with alignment files produced by
GMAP for differential analysis between two samples.
Cuffcompare and Cuffdiff were run employing default
parameters with refFlat.gtf file of Bos taurus genome
Btau7 build for reference annotation.
Functional analysis of gene isoforms
The Database for Annotation, Visualization and Integrated
Discovery (DAVID) v6.7 is a set of web-based functional
annotation tools for functional clustering of genes (Huang
et al. 2009). The functional clustering tool was used for
functional enrichment of isoforms with significant differ-
ential expression. Gene ontology was selected for func-
tional annotation with Fishers exact test at threshold value
of 0.001. Similarly, pathway analysis is also performed
with DAVID employing Fishers exact test at a threshold
value of 0.01.
Validation of potential novel splices isoforms
The tracking file provided by Cuffcompare was used to
infer splice isoforms unique to cancer by examining man-
ually. The transcripts with class code j were selected for
further evaluation. All novel isoforms detected by Cuff-
compare were classified based on their uniqueness in case
of HC, HN and present in both the cases. Further, these
novel isoforms were subjected to pathway-based clustering
using the highest classification stringency parameter in
DAVID v6.7. From these, novel splice isoforms clustered
under pathways associated with cancer were selected for
further in silico verification with IGV for actual read sup-
port and BLAT program of UCSC genome browser for
EST support. Transcripts assembled from the reads sup-
porting these splice isoforms were translated into protein
sequence for evaluation of protein change by comparison
with reference protein sequence and loss of functional
domain by blastp (Altschul et al. 1990). At last, fourteen
transcripts showed novel splicing both by Cufflinks and
UCSC genome browser and a significant change in protein
sequence with loss of functional motif was confirmed by
RT-PCR. The primers for RT-PCR were designed from
exon–exon junction in such a way that it should flank the
location of splice site change.
Quantitative real-time PCR (qPCR)
Four samples each of HC and HN were used to isolate total
RNA and differential expression of fourteen novel splice
isoforms was confirmed through RT-qPCR. The FASTA
sequences of reads spanning each selected transcript were
obtained from IGV and queried using web based tool Pri-
mer-BLAST (Ye et al. 2012) against Bos taurus reference
transcriptome to check the specificity of primers to amplify
only isoform transcripts. The expression level of novel
splice isoforms was quantified by RT-qPCR analysis on
ABI PRISM 7500 fast real-time PCR system (Applied
Biosystems) using Quantifast SYBR Green PCR master
mix (Qiagen). For PCR, all reactions were run in triplicate
and cycle threshold (CT) values for target novel transcripts
were normalized with endogenous reference gene RPLP0.
The fold change between two conditions was calculated
using the formula as described here:
Fold expression ¼ 2DDCT
where DCT is the average CT of target isoform - average
CT of endogenous control (RPLP0), and DDCT is the DCT
of target sample (HC) – DCT of calibrator sample (HN).
Results
Deep sequencing of Bos indicus horn transcriptome
To fully characterize and identify HC transcriptome, three
technical replicates of HC and HN sample were processed
for sequencing in three different runs. Thereafter, we
pooled sequencing data from all three technical replicates
of each sample for further analysis. As a result of
sequencing, we obtained a total of 0.59 million and 0.92
million high-quality reads comprising 239 million and 372
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million nucleotide bases for HN and HC tissue, respec-
tively. The reads used for analysis are submitted to the
bioProject NCBI and publically available with Accession
number PRJNA353983. Raw sequenced reads were pro-
cessed for quality filtering on the basis of quality score and
homopolymer runs. After quality filtering, we retained
535,067 and 849,077 reads, respectively, for HN and HC,
for further mapping and analysis of digital gene expression
profiling. We used GMAP software package for alignment
of sequencing sequenced reads against Bos taurus refer-
ence genome (bTau7). Approximately, 94.8 and 94.3% of
reads were successfully mapped to reference consisting of
80.3 and 79.7% of uniquely mapped reads, respectively, for
HC and HN. Detailed summary of mapping is described
elsewhere (Jakhesara et al. 2013b).
Differentially expressed gene isoforms
In total, 13,020 known isoforms were detected in HC while
12,728 known isoforms were detected in HN. Amongst
these, 2739 isoforms were detected only in HC, while 2447
isoforms were detected only in HN. In total, 1252 known
isoforms were up-regulated, while 1543 down-regulated
isoforms were observed with at least twofold difference in
HC tissue in comparison to HN. Top ten up- and down-
regulated isoforms with significant differential expression
are presented in Fig. 1a. More extensive lists of all 130
gene isoforms with significant differential expression in
HC are given in Table ST1. The fold change amongst top
50 up-regulated isoforms was from 11 to 2.7; while in case
of down-regulated isoforms, it was -8 to -2.5-fold.
Functional annotation of isoforms with significant
differential expression
All isoforms with differential expression were subjected to
functional analyses for gene ontology and pathway analy-
sis. The results revealed significant enrichment of cancer
(9.63E-04) and colorectal cancer (5.80E-03) pathways.
Gene ontology analyses also revealed enrichment of sev-
eral biological processes at threshold of 0.001. Mainly,
biological processes associated with angiogenesis, epithe-
lial cell development and differentiation, cell proliferation
and cell death were found to be enriched in differentially
expressed genes. Table 1 shows list of biological processes
and pathways enriched in differentially expressed isoforms.
Novel splice isoforms and their validation
Cuffcompare detected several transcripts with novel
splicing and all detected transcripts were classified as
intergenic, complete match, novel or unknown. A total of
4785 novel splice isoforms were detected by Cuffcompare,
which included 2432 isoforms unique for HC, 2055 iso-
forms unique for HN and 298 splice isoforms were
observed in both the conditions. Figure 1b shows top 10
novel up- and down-regulated splice isoforms in HC and
HN sample.
The large number of novel splice isoforms was found in
the present study; hence, to select the events relevant to the
cancer, KEGGpathway analyses and gene ontology analyses
were performed. Splice isoforms uniquely present in HC and
HN as well as common isoforms in both conditions were
subjected to KEGG pathway analyses using DAVID tool
employing highest sensitivity. As a result of this analysis,
three clusters (cancer-related pathways, cardiomyopathy and
amino acidmetabolism)were found to be enriched inHCand
HN. Based on this analysis and in silico verification with
IGV, respectively, 42, 43 and 17 splice isoforms were
selected for HC, HN and common to both conditions
(Table ST2). Figure 2 shows representative image of one
such novel splice isoform detected in FOS gene.
All splice isoforms were evaluated with blastp for pro-
tein change and details are available as Table ST2. Finally,
14 transcripts (7 isoforms uniquely expressed in HC, 5
transcripts uniquely expressed in HN and 2 isoforms pre-
sent in both) were selected for RT-qPCR verification based
on isoforms showing frame shift, loss of active domain and
association with cancer. Table 2 shows list of splice iso-
forms with type of variation selected for RT-qPCR. Pri-
mers designed from exon–exon junction for amplification
of these reference and variant transcript are given in
Table ST3.
The expression profile of 14 novel splice events and the
corresponding reference transcripts obtained with RT-
qPCR is presented in Fig. 3. The RT-qPCR analysis of HC
and HN tissue confirmed the expression of all reference as
well as novel splice isoforms except FGFR2 isoform,
which could not be amplified after repeated attempts on
different samples. However, we found some discrepancies
between RT-qPCR and RNA-Seq expression results. RT-
qPCR revealed down-regulation of all the splice isoforms
which were found to be up-regulated by RNA-Seq except
MAPK9, while in case of down-regulated isoforms com-
plete correlation was observed between RT-qPCR and
RNA-Seq.
Discussion
Cancer results from culmination of variety of genetic and
epigenetic changes occurring over a period of time. In such
a disease, it would be very much helpful to examine
molecular signatures that differentiate normal cell from
cancer one, as it will unravel nature and pathologic beha-
viour of a cancer cell. Here, we have made an attempt to
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unravel the novel splice isoforms expressed in horn cancer
as a result of complex RNA editing events through high-
throughput transcriptome analyses of horn cancer and its
normal counterpart. We found and validated several splice
isoforms expressed in horn cancer that might play a role in
progression of horn cancer. Our results show that high-
throughput transcriptome sequencing along with cautious
in silico and wet lab validation approaches can identify
novel splice isoforms associated with cancer.
Our analyses with Cuffdiff for differential expression
revealed several differentially expressed known isoforms in
HC. Many of the gene isoforms identified are known to be
involved in varieties of cancers; however, it would be
important to discuss top deregulated and differentially
expressed known gene isoforms in the present study.
Amongst top up-regulated isoforms, KRT gene isoforms
(KRT6A-11 fold, KRT6B-11 fold, KRT14-5 fold and
KRT17-5 fold) are expressed during differentiation of
simple and stratified epithelial tissues, which justify their
overexpression in horn cancer. These genes are also
reported for overexpression in squamous cell carcinoma of
lung (Hawthorn et al. 2006; Ohkura et al. 2005; Xue et al.
2011). At the second place, isoforms of CA1 (8-fold) and
CA2 (6.5-fold) genes were significantly overexpressed in
HC. Both the gene isoforms are implicated in more
advanced stage of the oral squamous cell carcinoma but not
with metastasis (Liu et al. 2012). These isoforms might
serve as a prospective biomarker to predict growth and
metastasis of tumour cells. Next up-regulated isoform
TNS4 variant (CTEN) is a member of family of proteins
that are localized to integrin-linked focal adhesions. CTEN
is implicated for increasing invasiveness through colony
formation and anchorage-independent growth in colorectal,
breast, gastric and pancreatic cancers (Liao et al. 2009;
Sakashita et al. 2008; Albasri et al. 2011; Al-Ghamdi et al.
2013). SAA3 isoform which encodes for serum amyloid A
protein has been widely studied as a marker in inflamma-
tion. Though its association in cancer is yet to be studied, it
is observed that it might play a role in pre-metastatic stage
and increases migration of metastatic cells to lungs (Hi-
ratsuka et al. 2008). This observation makes SAA3 a
plausible candidate target gene to track and prevent
Fig. 1 Top 10 up-/down-
regulated isoforms in horn
cancer. a Top 10 up-/down-
regulated isoforms with
significant differential
expression in HC. The
differentially expressed
isoforms in HC vs. those in
normal tissue were determined
by Cuffdiff. The fold change is
the ratio of FPKM of these
isoforms in HC to FPKM in
normal tissue. The differentially
expressed isoforms were ranked
on their fold change and 10
isoforms with the highest or
lowest fold changes are shown
in the figure. b Top 10
up-/down-regulated novel splice
variants in HC. The fold change
is the ratio of FPKM of these
isoforms in HC to FPKM in
normal tissue. The novel splice
variants were ranked on their
fold change and 10 splice
variants with the highest or
lowest fold changes are shown
here
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Table 1 List of pathways and functional categories deregulated in isoforms with significant differential expression in HC
Pathway Term P value
Pathways deregulated in HC
KEGG_PATHWAY bta05200:Pathways in cancer 9.63E-04
KEGG_PATHWAY bta05210:Colorectal cancer 5.80E-03
KEGG_PATHWAY bta04010:MAPK signalling pathway 2.26E-02
KEGG_PATHWAY bta04610:Complement and coagulation cascades 2.33E-02
KEGG_PATHWAY bta00680:Methane metabolism 5.11E-02
Gene ontology categories deregulated in HC
GOTERM_BP_FAT GO:0001944*vasculature development 1.39E-07
GOTERM_BP_FAT GO:0001568*blood vessel development 1.21E-06
GOTERM_BP_FAT GO:0048514*blood vessel morphogenesis 3.20E-06
GOTERM_BP_FAT GO:0001525*angiogenesis 2.98E-05
GOTERM_BP_FAT GO:0008285*negative regulation of cell proliferation 6.46E-05
GOTERM_BP_FAT GO:0060429*epithelium development 1.02E-04
GOTERM_MF_FAT GO:0003700*transcription factor activity 2.36E-04
GOTERM_BP_FAT GO:0035295*tube development 2.73E-04
GOTERM_BP_FAT GO:0006357*regulation of transcription from RNA polymerase II promoter 4.24E-04
GOTERM_BP_FAT GO:0010604*positive regulation of macromolecule metabolic process 4.64E-04
GOTERM_BP_FAT GO:0030855*epithelial cell differentiation 6.88E-04
GOTERM_BP_FAT GO:0008219*cell death 7.15E-04
GOTERM_BP_FAT GO:0010628*positive regulation of gene expression 7.84E-04
GOTERM_BP_FAT GO:0016265*death 8.32E-04
GOTERM_BP_FAT GO:0009967*positive regulation of signal transduction 9.19E-04
Fig. 2 Representative figure of typical novel splice variant identified
in our study. Figure was reconstructed using images from IGV and
UCSC genome browsers. At the top of the figure (blue peaks)
coverage tracks from IGV genome viewer are shown, while the
diagrammatic representation showing transcript structures for FOS
gene was taken from UCSC genome browser after BLAT analysis of
reads showing novel splice variation. Black blocks show exonic
regions, while regions with arrows indicate intronic regions. ESTs
supporting the splice variation are shown in red. The region marked
with faint yellow block shows the exon with splice change
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metastasis. CDH3 isoform encoding for adhesion glyco-
protein is a member of cadherin family responsible for
cell–cell adhesion and reported for its overexpression in
several cancers (Paredes et al. 2012). RCAN1 isoform
encodes for protein regulator of calcineurin 1 and its
overexpression inhibits migration of cancer cells (Espinosa
et al. 2009). Amongst top down-regulated isoforms,
BPIFB1 (8-fold) and BPIFA1 (6-fold) are members of a
family of secreted proteins with unclear biological role and
function, but it has been reported that these proteins are
differentially expressed in lung diseases (Bingle et al.
2012). CXCL17 is a latest member of the C-X-C chemo-
kine family proteins and aberrant expression of it promotes
tumour progression through angiogenesis (Matsui et al.
2012). Next down-regulated isoforms FOS and FOSB (7-
fold) are members of FOS family of proteins involved in
the regulation of cell proliferation, differentiation, and
transformation. These proteins are extensively studied and
their down-regulation is shown to promote tumour pro-
gression and metastasis (Kim et al. 2010). TPPP3 isoform,
also known as p20, is a new member of the tubulin poly-
merization promoting protein (TPPP) family playing a role
in microtubule assembly. TPPP3 protein is not reported in
cancer, but its knockdown suppressed cell proliferation and
induced cell cycle arrest in HeLa cells (Zhou et al. 2010).
Three isoforms GP2, RNASE4 and ADRA2A amongst top
down-regulated genes are not reported to be differentially
expressed in cancer. CITED2 isoform encoding for Cbp/
P300-Interacting Transactivator protein plays an important
role in cell proliferation by responding to TGF-a induction
and TGF-b suppression to orchestrate cellular proliferation
and quiescence, respectively. It is also reported that
CITED2 knockdown caused tumour shrinkage and
increased overall host mouse survival rates (Chou et al.
2012).
Gene ontology and pathway analyses of differentially
expressed isoforms revealed important insights about the
predominantly affected functions in HC. Gene ontology
suggested that HC is an actively growing tumour with
changes involving epithelial cell differentiation and
epithelium development with angiogenesis. Pathway anal-
yses suggested that cancer pathways and MAPK signalling
pathway responsible for uncontrolled cell growth are dif-
ferentially enriched in HC. Further in-depth analysis of
genes involved in MAPK/ERK signalling pathway is nec-
essary to support and confirm their role in uncontrolled cell
growth. Pathway analysis also resulted in clustering of
pathways related to cardiomyopathy. Investigation of the
genes (ACTN1, ACTN4, ADCY6, CTNNB1, DSP, EMD,
ITGA2, ITGA5, ITGAV, ITGB1, ITGB3, ITGB5, JUP,
PRKAA1, TPM1, TPM2, TPM4, and TCF7) clustered
under the cardiomyopathy pathways revealed involvement
of these genes in calcium binding pathways. As, calcium
binding is important for normal functioning of heart
Table 2 List of splice variants selected for validation along with type of variation and protein change




Type of variation Chr. Protein change
FOS NM_182786.2 Yes Alternate 30 splicing exon 2 10 Premature stop codon after 104 aa
MAPK9 NM_001046369.1 Yes Alternate 50 splicing exon 10 7 Premature stop codon after 293 aa
FGFR1 NM_001110207.1 No Skipping of exon 2, alternate 30
splicing exon 3
27 Deletion of aa 31–117, loss of Ig1_FGFR domain
FGFR2 NM_001205310.1 No Skipping of exon 10–13 26 Deletion of aa 448–639, loss of PTKc_FGFR domain
MFAP4 NM_001080217.1 No skipping of exon 2–5, alternate 50
splicing exon 6
19 Premature stop codon after 157 aa, part of fibrinogen
related domain lost
HSP90AB1 NM_001079637.1 Yes Intron retention between exon 7–8 23 Premature stop codon after 380 aa, HSP90 domain lost
RPS6KB1 NM_205816.1 No Alternative 30 splicing exon 7 19 Premature stop codon after 234 aa, part of STKc domain
lost
CREBBP NM_001164022.1 No Alternate 30 splicing exon 9 25 Premature stop codon after 649 aa, Creb domain lost
CRK NM_001192334.1 Yes Novel exon between 1–2, alternate
30 splicing of exon 2
19 Premature stop codon after 204 aa, SH3 domain lost
PTPN6 NM_001098017.1 No Skipping of exon 12 5 Premature stop codon after 457 aa, part of PTPc domain
lost
PTPRU NM_001191494.1 No Alternate 50 splicing exon 7 2 Premature stop codon after 312 aa, several domains of
fibronectine and PTPc are lost
SUFU NM_001098083.2 No Alternate exon 11 26 Same size of protein with different terminal 52 aa,
different C terminal domain than ref.
FN1 NM_001163778.1 No Skipping of exon 32 2 Deletion of 1631–1720 aa without frame shift
FN1 NM_001163778.1 Yes Novel exon 25 2 Addition of 91 aa after position 1266 without frame shift
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through binding with troponins, enrichment of these genes
resulted in the enrichment of cardiomyopathy pathways
(Farah and Reinach 1995).
Our analyses with Cuffcompare detected several tran-
scripts with novel splicing amongst all detected transcripts
classified as intergenic, complete match, novel or
unknown. To reduce these novel splicing events to more
meaningful conclusion and to reduce number of false
positives, we employed rigorous bioinformatics analysis.
As a first step, we reduced these numbers by selecting only
those novel splice events which were clustered along with
cancer pathways in pathway analysis; this helped us to
select splicing events which might be associated with HC.
Second, we analysed all selected splicing events by UCSC
genome browser, BLAT and IGV to check for EST sup-
port, to verify novel splicing and to eliminate splicing
events not supported by reads, respectively. We also
eliminated the events which were present at the end of the
reads. As a third and final step, we performed blastp of the
translated protein sequences of novel splices transcripts to
examine amino acid changes in the sequence of the protein.
In this step, we selected only splicing events which resulted
in significant protein change or premature stop codon.
Eventually, we selected 14 novel splicing events and
confirmed their presence by end-point PCR and by RT-
qPCR. This intensive selection and filtering of novel
splicing events made sure that only splice isoforms which
might be significantly associated with HC are analysed.
Our validation of selected novel splicing events
revealed discrepancy in the expression profiles obtained
by RT-qPCR with that of RNA-Seq. The contrasting
differential expression profile obtained with RT-qPCR in
few isoforms reveals the limitation of RNA-Seq to iden-
tify reads originating from specific isoform and therefore
requires additional validation using RT-qPCR for changes
in gene expression, while confirmation of almost all
splicing events by RT-qPCR denotes reliability of RNA-
Seq for high throughput detection of novel splicing
events. Additionally, differential expression of all in sil-
ico selected splice isoforms across multiple cancer sam-
ples validates our approach for selection of novel splice
isoforms relevant to cancer. We found a consistent pattern
of down-regulation or up-regulation in both the reference
and variant isoforms across all four samples, which
Fig. 3 RT-qPCR analysis of
novel splicing events. RT-qPCR
analysis of novel splicing events
on multiple horn cancer
samples. The relative expression
of reference (a) and variant
(b) isoforms of candidate genes
was analysed in four horn
cancer tissue samples relative to
four normal horn tissues. Gene
names indicated below are the
columns for respective genes,
where _R and _V following




quantitation (log2RQ) of each
candidate isoform in cancer
tissues was plotted against their
expression in normal tissue.
Error bar indicates standard
error of mean (SEM) of four
biological replicates of HC or
HN
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emphasizes the possible development of these isoforms as
biomarkers for horn cancer. Additionally, 9 out of 14
variants that we selected contain premature termination
codon as a result of novel splicing; however, it requires
further detailed investigation of effects produced by
nonsense-mediated decay of these aberrant transcript on
overall expression of the gene, if any.
Since horn cancer has been analysed previously for
detection of novel splice variants (Patel et al. 2013), we
sought to identify any differences or similarities between
results, if any. Surprisingly, none of the previously iden-
tified and validated eight splice isoforms were detected in
the present study. However, several reasons could be
attributed for such an observation. As the previous study
was a preliminary study involving small size of dataset
without any quality filtering of the data, skipping of all the
previous events identified is quite possible. Second, the
present study identified and selected a set of novel splice
isoforms whose probability of association with horn cancer
is much more, as the events were identified in a logical and
systematic way after enrichment of genes associated with
horn cancer using GO analysis. Third, the software used for
assembly (GS de novo assembler vs Cufflinks) and detec-
tion of splice events (Blat vs Cuffcompare) was different
and it is important to note that full-length transcript
assembly is very difficult, which is additionally compli-
cated by artifacts in sample preparation, sequencing and
read alignment. The above listed reasons and small-scale
analysis without any type of selection criteria of previously
generated dataset resulted in skipping of already identified
novel splice isoforms. Nonetheless, the findings reported in
the present study are absolutely novel and add to existing
knowledge about splice isoforms in HC.
The 14 novel splicing events selected for verification
might be considered as biomarkers as their potential effect
on cancer progression. Consistent down-regulation of both
the reference and variant was found for FOS gene by RT-
qPCR across four HC samples. Alternate 30 splicing of
exon2 in FOS resulted in premature stop codon just after
position 104 aa culminating in loss of basic leucine zipper
DNA-binding domain responsible for specific DNA bind-
ing. Although transcripts containing premature stop codon
are subjected to nonsense-mediated decay (NMD), it has
been studied that stress response elicited in tumour
microenvironment leads to inhibition of NMD (Wang et al.
2011). Further studies are required to support such specu-
lation and to study the effect of aberrant expression of this
splice isoform on tumour progression. MAPK9 splice iso-
form which is a member of MAP kinase family of genes is
also called as c-Jun N-terminal kinases (JNK2) involved in
proliferation, differentiation, transcription regulation and
development (Raciti et al. 2012). MAPK9 splice isoform
exhibited premature stop codon after 293 aa and loss of
domain responsible for serine/threonine kinase activity. We
observed consistent up-regulation of both the reference and
variant for MAPK9 gene by RT-qPCR across four HC
samples. FGFR1 and FGFR2 are the members of the
fibroblast growth factor receptor (FGFR) family of genes
with a variety of roles in cancer (Holzmann et al. 2012).
Splice variation in FGFR1 led to loss of IG1 domain which
leads to activation of distinct signalling cascades (Zhang
et al. 2006), while splice change observed in FGFR2 with
loss of PTKc domain could not be validated with RT-PCR.
Both the genes FGFR1 and FGFR2, reference and variant,
were found to be down-regulated by RT-qPCR. MFAP4
encodes for bovine microfibril-associated protein with
probable role in calcium-dependent cell adhesion or
intercellular interactions. We also observed intron retention
in HSP90AB1 transcript resulting in premature termination
after 380 aa position. HSP90AB1 plays an important role in
folding newly synthesized proteins or stabilizing and
refolding denatured proteins after stress (Cheng et al.
2012). RPS6KB1 splice isoform is part of a protein kinase
family involved in the regulation of cellular growth, insu-
lin, and cellular energy. Overexpression of RPS6KB1 plays
an important role in hepatocellular carcinoma (Li et al.
2012) and correlates with adverse prognosis. Similarly,
CREBBP (Mullighan et al. 2011), CRK (Sriram and Birge
2010), PTPN6 and PTPRU (Hoekstra et al. 2012) genes
which might play a probable role in cancer revealed pre-
mature termination with loss of domains related to function
as shown in Table 2. SUFU gene encodes negative regu-
lator of Hedgehog signalling pathway exhibiting signalling
cascade that plays a role in pattern formation and cellular
proliferation during development. The gene is not well
studied in the bovine, but two isoforms with different c
terminal have been reported in humans (Tostar et al. 2012).
SUFU splice isoform identified in this study encodes for
longer isoform with different C terminal than reference.
FN1 encodes fibronectin, a glycoprotein present at the cell
surface and in extracellular matrix and is involved in cell
adhesion and migration processes including embryogene-
sis, wound healing, blood coagulation, host defense, and
metastasis (Goossens et al. 2009). Splice variation of novel
exon 25 and skipping of exon 32 revealed in this isoform
and resulted in varying length of protein without frame-
shift. In total, we confirmed expression of these 13 novel
splice isoforms, however it remains to be investigated
whether these putative protein isoforms are indeed trans-
lated in to proteins and in turn functional consequences of
these variations. Furthermore, we found an interesting
aspect of our analysis of AS events in HC as majority of
novel splice isoforms supported by ESTs reported in
bovine foetus. This may be due to the activation of genes or
isoforms taking part in the foetal development by car-
cinogenic genes. This observation is supported by an
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earlier study showing antigenic similarity between bovine
horn cancer and foetal tissue (Kuchroo et al. 1979).
Conclusion
The results reported here are novel in terms of alternative
splicing prevailing in HC and have potential implications
for intervention of HC at molecular level. Herein, we
reported and confirmed several novel splice isoforms dif-
ferentially expressed in HC which might be useful as
biomarkers to diagnose the HC at early stage. Rigorous and
cautious filtering of several novel splice isoforms resulted
in splice isoforms, most probably associated with HC. In
summary, we have identified and validated fourteen puta-
tive novel isoforms which are significantly associated with
HC and discussed their possible involvement in cancer
progression. Further extensive follow-up analysis of novel
splice isoforms found in this study might be useful in the
development of prospective intervention strategies for HC.
The results reported here might also be helpful to under-
stand other cancers prevalent in other species and refine the
available information on transcriptome repertoire of bovine
species.
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